Opposing regulation of neutrophil apoptosis through the formyl peptide receptor-like 1/lipoxin A4 receptor: Implications for resolution of inflammation

Journal of Leukocyte Biology

Volumn 84, Issue 3, 2008, Pages 600-606

  El Kebir, Driss ^a   József, Levente ^a   Filep, János G ^a  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

Acute phase reactants; Lipid mediators

Indexed keywords

FORMYLPEPTIDE RECEPTOR LIKE 1; LIGAND; SERUM AMYLOID A;

APOPTOSIS; HUMAN; INFLAMMATION; LEUKOCYTE ACTIVATION; METABOLIC ACTIVATION; MODULATION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW; SURVIVAL; TISSUE INJURY;

ANNEXIN A1; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; ASPIRIN; HUMANS; LIPOXINS; NEUTROPHIL ACTIVATION; NEUTROPHIL INFILTRATION; NEUTROPHILS; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, LIPOXIN; SERUM AMYLOID A PROTEIN;

EID: 50849131923     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1107765     Document Type: Review

References (96)

1. Nathan, C. (2002) Points of control of inflammation. Nature 420, 846-852.
2. Weiss, S. J. (1989) Tissue destruction by neutrophils. N. Engl. J. Med. 320, 365-375.
3. Savill, J. S., Wyllie, A. H., Henson, J. E., Walport, M. J., Henson, P. M., Haslett, J. C. (1989) Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J. Clin. Invest. 83, 865-875.
4. Colotta, F., Re, F., Polentarutti, N., Sozzani, S., Mantovani, A. (1992) Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80, 2012-2020.
5. Lee, A., Whyte, M. K. B., Haslett, C. (1993) Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J. Leukoc. Biol. 54, 283-288.
6. Savill, J., Dransfield, I., Gregory, C., Haslett, C. (2002) A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2, 965-975.
7. Gilroy, D. W., Lawrence, T., Perretti, M., Rossi, A. G. (2004) Inflammatory resolution: new opportunities for drug discovery. Nat. Rev. Drug Discov. 3, 401-416.
8. Simon, H. U. (2003) Neutrophil apoptosis pathways and their modifications in inflammation. Immunol. Rev. 193, 101-110.
9. Matute-Bello, G., Liles, W. C., Radella, F., Steinberg, K. P., Ruzinski, J. T., Jonas, M., Chi, E. Y., Hudson, L. D., Martin, T. R. (1997) Neutrophil apoptosis in the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 156, 1969-1977.
10. Keel, M., Ungethum, U., Steckholzer, U., Niederer, E., Hartung, T., Trentz, O., Ertel, W. (1997) Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during sepsis. Blood 90, 3356-3363.
11. Garlichs, C. D., Eskafi, S., Cicha, I., Schmeisser, A., Walzog, B., Raaz, D., Stumf, C., Yilmaz, A., Bremer, J., Ludwig, J., Daniel, W. G. (2004) Delay of neutrophil apoptosis in acute coronary syndromes. J. Leukoc. Biol. 75, 828-835.
12. Su, S. B., Gong, W., Gao, J. L., Shen, W., Murphy, P. M., Oppenheim, J. J., Wang, J. M. (1999) A seven-transmembrane, G-protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 189, 395-402.
13. He, R., Sang, H., Ye, R. D. (2003) Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R. Blood 101, 1572-1581.
14. Chiang, N., Serhan, C. N., Dahlen, S. E., Drazen, J. M., Hay, D. W. P., Rovati, G. E., Shimizu, T., Yokomizo, T., Brink, C. (2006) The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Pharmacol. Rev. 58, 463-487.
15. 4 receptor. Nat. Med. 8, 1296-1302.
16. Le, Y., Gong, W., Tiffany, H. L., Tumanov, A., Nedospasov, S., Shen, W., Dunlop, N. M., Gao, J. L., Murphy, P. M., Oppenheim, J. J., Wang, J. M. (2001) Amyloid (β)42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1. J. Neurosci. 21, RC123.
17. Resnati, M., Pallavicini, I., Wang, J. M., Oppenheim, J., Serhan, C. N., Romano, M., Blasi, F. (2002) The fibrinolytic receptor for urokinase activates the G-protein-coupled chemotactic receptor FPRL1/LXA4R. Proc. Natl. Acad. Sci. USA 99, 1359-1364.
18. 4 receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. J. Exp. Med. 191, 1197-1208.
19. 106-126 is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-like 1. J. Immunol. 166, 1448-1451.
20. Deng, X., Ueda, H., Su, S. B., Gong, W., Dunlop, N. M., Gao, J. L., Murphy, P. M., Wang, J. M. (1999) A synthetic peptide derived from human immunodeficiency virus type 1 gp120 downregulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the 7-transmembrane G-protein-coupled receptor FPRL1/ LXA4R. Blood 94, 1165-1173.
21. Gabay, C., Kushner, I. (1999) Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340, 448-454.
22. Meek, R. L., Urieli-Shoval, S., Benditt, E. P. (1994) Expression apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc. Natl. Acad. Sci. USA 91, 3186-3190.
23. Kumon, Y., Suehiro, T., Hashimoto, K., Nakatani, K., Sipe, J. D. (1999) Local expression of acute phase serum amyloid A mRNA in rheumatoid arthritis synovial tissue and cells. J. Rheumatol. 26, 785-790.
24. O'Hara, R., Murphy, E. P., Whitehead, A. S., Fitzgerald, O., Bresnihan, B. (2000) Acute-phase serum amyloid A production by rheumatoid arthritis synovial tissue. Arthritis Res. 2, 142-144.
25. Jensen, L. E., Whitehead, A. S. (1998) Regulation of serum amyloid A protein expression during the acute-phase response. Biochem. J. 334, 489-503.
26. Urieli-Shoval, S., Linke, R. P., Matzner, Y. (2000) Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Curr. Opin. Hematol. 7, 64-69.
27. Bausserman, L. L., Herbert, P. N., Rodger, R., Nicolosi, R. J. (1984) Rapid clearance of serum amyloid A from high-density lipoproteins. Biochim. Biophys. Acta 792, 186-191.
28. Coetzee, G. A., Stachan, A. F., van der Westhuyzen, D. R., Hopee, H. C., Jeenah, M. S., de Beer, F. C. (1986) Serum amyloid A-containing human high density lipoprotein 3: density, size, and apolipoprotein composition. J. Biol. Chem. 261, 9644-9651.
29. Malle, E., de Beer, F. C. (1996) Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice. Eur. J. Clin. Invest. 26, 427-435.
30. Cunnane, G., Grehan, S., Geoghegan, S., McCormack, C., Shields, D., Whitehead, A. S., Bresnihan, B., Fitzgerald, O. (2000) Serum amyloid A in the assessment of early inflammatory arthritis. J. Rheumatol. 27, 58-63.
31. Liuzzo, G., Biasucci, L. M., Gallimore, R. J., Grillo, R. L., Rebuzzi, A. G., Pepys, M. B., Maseri, A. (1994) The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N. Engl. J. Med. 331, 417-424.
32. Johnson, B. D., Kip, K. E., Marroquin, O. C., Ridker, P. M., Kelsey, S. F., Shaw, L. J., Pepine, C. J., Sharaf, B., Bairey Merz, C. N., Sopko, G., Olson, M. B., Reis, S. E. (2004) Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women. The National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 109, 726-732.
33. Buffon, A., Biasucci, L. M., Liuzzo, G., D'Onofrio, G., Crea, F., Maseri, A. (2002) Widespread coronary inflammation in unstable angina. N. Engl. J. Med. 347, 5-12.
34. Banka, C. L., Yuan, T., de Beer, M. C., Kindy, M., Curtiss, L. K., de Beer, F. C. (1995) Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux. J. Lipid Res. 36, 1058-1065.
35. Shah, C., Hari-Dass, R., Raynes, J. G. (2006) Serum amyloid A is an innate immune opsonin for Gram-negative bacteria. Blood 108, 1751-1757.
36. Badolato, R., Wang, J. M., Stornello, S-L., Ponzi, A. N., Duse, M., Musso, T. (2000) Serum amyloid A is an activator of PMN antimicrobial functions: induction of degranulation, phagocytosis, and enhancement of anti-Candida activity. J. Leukoc. Biol. 67, 381-386.
37. Furlaneto, C. J., Campa, A. (2000) A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-α, interleukin-1β, and interleukin-8 by human blood neutrophil. Biochem. Biophys. Res. Commun. 268, 405-408.
38. Vallon, R., Freuler, F., Desta-Tsedu, N., Robeva, A., Dawson, J., Wenner, P., Engelhardt, P., Boes, L., Schnyder, J., Tschopp, C., Urfer, R., Baumann, G. (2001) Serum amyloid A (apoSAA) expression is up-regulated in rheumatoid arthritis and induces transcription of matrix metalloproteinases. J. Immunol. 166, 2801-2807.
39. Patel, H., Fellowes, R., Coade, S., Woo, P. (1998) Human serum amyloid A has cytokine-like properties. Scand. J. Immunol. 48, 410-418.
40. He, R. L., Zhou, J., Hanson, C., Chen, J., Ye, R. D. (2007) The acute-phase protein serum amyloid A induces G-CSF expression and granulocytosis. J. Leukoc. Biol. Suppl. 2007, 44-45.
41. Badolato, R., Wang, J. M., Murphy, W. J., Lloyd, A. R., Michiel, D. F., Bausserman, L. L., Kelvin, D. J., Oppenheim, J. J. (1994) Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J. Exp. Med. 180, 203-209.
42. Björkman, L., Karlsson, J., Karlsson, A., Rabiet, M-J., Boulay, F., Fu, H., Bylund, J., Dahlgren, C. (2008) Serum amyloid A mediates human neutrophil production of reactive oxygen species through a receptor independent of formyl peptide receptor like-1. J. Leukoc. Biol. 83, 245-253.
43. phox deficient patients to lipopolysaccharide and serum amyloid A. Immunol. Lett. 94, 43-46.
44. 4 stable analogs that block transmigration and adhesion of human neutrophils. Biochemistry 34, 14609-14615.
45. Claria, J., Serhan, C. N. (1995) Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc. Natl. Acad. Sci. USA 92, 9475-9479.
46. 4 by pioglitazone and atorvastatin in the rat. Circulation 114, 929-935.
47. Levy, B. D., Clish, C. B., Schmidt, B., Gornert, K., Serhan, C. N. (2001) Lipid mediator class switching during acute inflammation: signals in resolution. Nat. Immunol. 2, 612-619.
48. Bonnans, C., Vachier, I., Chavis, C., Godard, P., Bousquet, J., Chanez, P. (2002) Lipoxins are potential endogenous antiinflammatory mediators in asthma. Am. J. Respir. Crit. Care Med. 165, 1531-1535.
49. 4 and inhibits thromboxane in a randomized human trial. Proc. Natl. Acad. Sci. USA 101, 15178-15183.
50. McMahon, B., Godson, C. (2004) Lipoxins: endogenous regulators of inflammation. Am. J. Physiol. Renal Phsyiol. 286, F189-F201.
51. 4 receptor interaction. Biochemistry 34, 16678-16686.
52. Filep, J. G., Zouki, C., Petasis, N. A., Hachicha, M., Serhan, C. N. (1999) Anti-inflammatory actions of lipoxin A(4) stable analogs are demonstrable in human whole blood: modulation of leukocyte adhesion molecules and inhibition of neutrophil-endothelial interactions. Blood 94, 4132-4142.
53. 4. FASEB J. 13, 903-911.
54. 4 inhibit peroxynitrite formation, NF-κB and AP-1 activation, and IL-8 gene expression in human leukocytes. Proc. Natl. Acad. Sci. USA 99, 13266-13271.
55. 4 receptor. J. Biol. Chem. 272, 6972-6978.
56. 4 and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. Clin. Sci. 77, 195-203.
57. 4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation. J. Exp. Med. 200, 69-78.
58. 4 and aspirin-triggered lipoxin are SOCS-2 dependent. Nat. Med. 12, 330-334.
59. 4 analogs block extracellular signal-regulated kinase-dependent TNF-α secretion from human T cells. J. Immunol. 170, 6266-6272.
60. Hayhoe, R. P., Kamal, A. M., Solito, E., Flower, R. J., Cooper, D., Perretti, M. (2006) Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement. Blood 107, 2123-2130.
61. Gavins, F. N., Yona, S., Kamal, A. M., Flower, R. J., Perretti, M. (2003) Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms. Blood 101, 4140-4147.
62. Gavins, F. N., Kamal, A. M., D'Amico, M., Oliani, S. M., Perretti, M. (2005) Formyl-peptide receptor is not involved in the protection afforded by annexin 1 in murine acute myocardial infarct. FASEB J. 19, 100-102.
63. Godson, C., Mitchell, S., Harvey, K., Petasis, N. A., Hogg, N., Brady, H. R. (2000) Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J. Immunol. 164, 1663-1667.
64. Maderna, P., Yona, S., Perretti, M., Godson, C. (2005) Modulation of phagocytosis of apoptotic neutrophils by supernatant from dexamethasone-treated macrophages and annexin-derived peptide Ac(2-26). J. Immunol. 174, 3727-3733.
65. 4: a new class of ligand for the Ah receptor. Biochemistry 38, 7594-7600.
66. El Kebir, D., József, L., Pan, W., Petasis, N. A., Serhan, C. N., Filep, J. G. (2007) Aspirin-triggered lipoxins override the apoptosis-delaying action of serum amyloid A in human neutrophils: a novel mechanism for resolution of inflammation. J. Immunol. 179, 616-622.
67. Christenson, K., Björkman, L., Tängemo, C., Bylund, J. (2008) Serum amyloid A inhibits apoptosis of human neutrophils via a P2X7-sensitive pathway independent of formyl peptide receptor-like 1. J. Leukoc. Biol. 83, 139-148.
68. Khreiss, T., József, L., Hossain, S., Chan, J. S. D., Potempa, L. A., Filep, J. G. (2002) Loss of pentameric symmetry of C-reactive protein is associated with delayed apoptosis of human neutrophils. J. Biol. Chem. 277, 40775-40781.
69. Walther, A., Riehemann, K., Gerke, V. (2000) A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR. Mol. Cell 5, 831-840.
70. Bae, Y. S., Lee, H. Y., Jo, E. J., Kim, J. I., Kang, H. K., Ye, R. D., Kwak, J. Y., Ryu, S. H. (2004) Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling. J. Immunol. 173, 607-614.
71. József, L., Khreiss, T., Filep, J. G. (2004) CpG motifs in bacterial DNA delay apoptosis of neutrophil granulocytes. FASEB J. 18, 1776-1778.
72. Klein, J. B., Rane, M. J., Scherzer, J. A., Coxon, P. Y., Kettritz, R., Mathiesen, J. M., Buridi, A., McLeish, K. R. (2000) Granulocyte-macrophage colony-stimulating factor delays neutrophil constitutive apoptosis through phosphoinositide 3-kinase and extracellular signal-regulated kinase pathways. J. Immunol. 164, 4286-4291.
73. Zamzami, N., Marchetti, P., Castedo, M., Zanin, C., Vayssière, J. L., Petit, P. X., Kroemer, G. (1995) Reduction of mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J. Exp. Med. 181, 1661-1672.
74. Reed, J. C. (1997) Double identity for proteins of the Bcl-2 family. Nature 387, 773-776.
75. Maianski, N. A., Mul, F. P. J., van Buul, J. D., Roos, D., Kuijpers, T. W. (2002) Granulocyte colony-stimulating factor inhibits the mitochondria-dependent activation of caspase-3 in neutrophils. Blood 99, 672-679.
76. Maianski, N. A., Geissler, J., Srinivasula, S. M., Alnemri, E. S., Roos, D., Kuijpers, T. W. (2004) Functional characterization of mitochondria in neutrophils: a role restricted to apoptosis. Cell Death Differ. 11, 143-153.
77. + efflux prevents mitochondrial dysfunction, and suppresses caspase-3-, apoptosis-inducing factor-, and endonuclease G-mediated constitutive apoptosis in human neutrophils. Cell. Signal. 18, 2302-2313.
78. Frasch, S. C., Nick, J. A., Fadok, V. A., Bratton, D. L., Worthen, G. S., Henson, P. M. (1998) p38 Mitogen-activated protein kinase-dependent and -independent intracellular signal transduction pathways leading to apoptosis in human neutrophils. J. Biol. Chem. 273, 8389-8397.
79. Alvarado-Kristensson, M., Porn-Ares, M. I., Grethe, S., Smith, D., Zheng, L., Andersson, T. (2002) p38 Mitogen-activated protein kinase and phosphatidylinositol 3-kinase activities have opposite effects on human neutrophil apoptosis. FASEB J. 16, 129-131.
80. 7 receptors. Am. J. Physiol. Cell Physiol. 279, C1189-C1197.
81. Beigi, R. D., Kertesy, S. B., Aquilina, G., Dubyak, C. R. (2003) Oxidized ATP (oATP) attenuates proinflammatory signaling via P2 receptor-independent mechanisms. Br. J. Pharmacol. 140, 507-519.
82. Solito, E., Kamal, A., Russo-Marie, F., Buckingham, J. C., Marullo, S., Perretti, M. (2003) A novel calcium-dependent proapoptotic effect of annexin 1 on human neutrophils. FASEB J. 17, 1544-1546.
83. Liles, W. C., Dale, D. C., Klebanoff, S. J. (1995) Glucocorticoids inhibit apoptosis of human neutrophils. Blood 86, 3181-3188.
84. Vergnolle, N., Coméra, C., Moré, J., Alvinerie, M., Buéno, L. (1997) Expression and secretion of lipocortin 1 in gut inflammation are not regulated by pituitary-adrenal axis. Am. J. Physiol. 273, R623-R629.
85. Zouki, C., Ouellet, S., Filep, J. G. (2000) The anti-inflammatory peptides, antiflammins, regulate the expression of adhesion molecules on human leukocytes and prevent neutrophil adhesion to endothelial cells. FASEB J. 14, 572-580.
86. Perretti, M., Solito, E. (2004) Annexin 1 and neutrophil apoptosis. Biochem. Soc. Trans. 32, 507-510.
87. Arur, S., Uche, U. E., Rezaul, K., Fong, M., Scranton, V., Cowan, A. E., Mohler, W., Han, D. K. (2003) Annexin I is an endogenous ligand that mediates apoptotic cell engulfment. Dev. Cell 4, 587-598.
88. Liu, Y., Cousin, J. M., Hughes, J., van Damme, J., Seckl, J. R., Haslett, C., Dransfield, I., Savill, J., Rossi, A. G. (1999) Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. J. Immunol. 162, 3639-3646.
89. 4 receptor. J. Exp. Med. 180, 253-260.
90. Serhan, C. N., Savill, J. (2005) Resolution of inflammation: the beginning programs the end. Nat. Immunol. 6, 1191-1197.
91. 4 induces apoptosis in rat renal interstitial fibroblasts. Prostaglandins Leukot. Essent. Fatty Acids 73, 127-137.
92. Mitchell, S., Thomas, G., Harvey, K., Cottel, D., Reville, K., Berlasconi, G., Petasis, N. A., Erwig, L., Rees, A. J., Savill, J., Brady, H. R., Godson, C. (2002) Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo. J. Am. Soc. Nephrol. 13, 2497-2507.
93. Rossi, A. G., Sawatzky, D. A., Walker, A., Ward, C., Sheldrake, T. A., Riley, N. A., Caldicott, A., Martinez-Losa, M., Walker, T. R., Duffin, R., Gray, M., Crescenzi, E., Martin, M. C., Brady, H. R., Savill, J. S., Dransfield, I., Haslett, C. (2006) Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. Nat. Med. 12, 1056-1064.
94. 4 in human mesangial cells. Differential activation of MAP kinases through distinct receptors. J. Biol. Chem. 275, 27566-27575.
95. Mitchell, D., Rodgers, K., Hanly, J., McMahon, B., Brady, H. R., Martin, F., Godson, C. (2004) Lipoxins inhibit Akt/PKB activation and cell cycle progression in human mesangial cells. Am. J. Pathol. 164, 937-946.
96. 4 inhibits proliferation of human lung fibroblasts induced by connective tissue growth factor. Am. J. Respir. Cell Mol. Biol. 34, 65-72.